Kobayshi K, Suyama K, Katsuya H, Izawa N, et al. A phase II multicenter trial assessing the efficacy and safety of first-line S-1 + ramucirumab in elderly patients with advanced/recurrent gastric cancer: KSCC1701. Eur J Cancer 2022;166:279-286.
PMID: 35349925